天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook
Chinese English Germany Korean

Aladdin Scientific 企業(yè)の連絡(luò)先情報(bào)

名前:Aladdin Scientific
電話番號(hào):-
電子メール:tp@aladdinsci.com
國(guó)籍:United States
ウェブサイト:www.aladdinsci.com/
商品の合計(jì)數(shù):52924
473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530

製品カタログ

NLRP3/AIM2-IN-2791840-86-3C15H15NO3
4-Nonylphenol-d54‐N‐ノニルフェノール‐2,3,5,6‐D4,OD358730-95-7C15H19D5O
NF-κΒ activator 12387524-59-4C16H11FN2O2S
N-Nornuciferine(6aR)-4,5,6,6a-テトラヒドロ-1,2-ジメトキシ-7H-ジベンゾ[de,g]キノリン4846-19-9C18H19NO2
NSP-AS211106-69-3C28H28N2O8S2
Namitecan372105-27-6C23H22N4O5
NCGC002296001338824-20-6C30H29N3O3
N3-PEG3-CH2CH2COOH1056024-94-2C9H17N3O5
Nelonemdaz potassium916214-57-8C15H9F7KNO3
NFAT Transcription Factor Regulator-1245747-71-1C17H10F6N4O2
NAMPT inhibitor-linker 12241019-57-6C36H37FN6O6
NVP-BHG712 isomer2245892-85-5C26H20F3N7O
Nampt-IN-32121591-52-2C29H25N7O2
NMS-P5151262395-13-0C21H29N3O2
Neocryptotanshinoneネオクリプトタンシノン109664-02-0C19H22O4
NCGC002445362003260-55-5C25H22N2O2
Nicodicosapent1269181-69-2C28H39N3O2
NucPE11404091-23-1C29H30BNO5
Naphthoquine phosphate173531-58-3C24H31ClN3O5P
NaV1.7 inhibitor-11494585-79-3C23H30FNO4S
Nodosin13-デオキシ-5β-ヒドロキシエンメイン10391-09-0C20H26O6
Nelociguat625115-52-8C19H17FN8O2
NCRW0005-F05342779-66-2C16H13F2NO2
NVX-2073β-アセトキシルパ-20(30)-エン-28-酸2-アミノ-3-ヒドロキシ-2-(ヒドロキシメチル)プロピル745020-66-0C36H59NO6
N-FeruloyloctopamineN-フェルロイルオクトパミン66648-44-0C18H19NO5
N-(3-Methoxybenzyl)PalmitamideN-(3-メトキシベンジル)ヘキサデカンアミド847361-96-0C24H41NO2
N-Desethyl amodiaquine dihydrochloride79049-30-2C18H20Cl3N3O
Niraparib (R-enantiomer)1038915-58-0C19H20N4O
N-deacetylated BMS-2022310135-18-1C23H27N3O2
Neoseptin 3ネオセプチン31622863-21-1C29H34N2O4
NF-56-EJ402380230-73-7C27H29N3O3
Nav1.1 activator 12332897-85-3C24H23F3N4O
N7-Methyl-guanosine-5'-triphosphate-5'-adenosine diammonium75252-10-7C21H32N11O17P3
N-p-trans-CoumaroyltyramineN-p-trans-クマロイルチラミン36417-86-4C17H17NO3
NMS-P7151202055-32-0C35H39F3N8O3
Nampt-IN-11698878-14-6C20H25N3O5S
NRX-26632763260-34-8C20H13F3N2O5
Nevadensin5,7-ジヒドロキシ-6,8,4'-トリメトキシフラボン10176-66-6C18H16O7
Naquotinib mesylateナコチニブメシル酸塩1448237-05-5C31H46N8O6S
NRX-2522622438637-61-5C23H17Cl2F3N2O4S
(Rac)-NMDAR antagonist 12435557-99-4C20H20BrN3O2
Necroptosis-IN-11391980-92-9C12H10ClN3O2
Niclosamide-13C6ニクロサミド-13C6 水和物1325808-64-7C13H8Cl2N2O4
N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide883715-23-9C26H39NO2
Naproxen etemesilナプロキセンエテメシル385800-16-8C17H20O5S
[Leu31,Pro34]-Neuropeptide Y (porcine)[LEU31, PRO34]-ニューロペプチドY, ブタ125580-28-1C190H286N54O56
NCT-5062231098-99-8C25H23FN4O3S
N-[(4-Aminophenyl)methyl]adenosine95523-13-0C17H20N6O4
Narmafotinib1393653-34-3C28H32F3N5O2
N-ε-propargyloxycarbonyl-L-lysine hydrochloride1428330-91-9C10H16N2O4
NAI-N31612756-29-2C10H8N6O
Nucleoprotein (396-404)158475-79-7C50H71N13O14
Nigranoic acidニグラン酸39111-07-4C30H46O4
Nagilactone B(1S)-1,2,3,3a,5aβ,6,10b,10cβ-オクタヒドロ-1,2α,6α-トリヒドロキシ-3aβ,10bα-ジメチル-7-イソプロピル-4H,9H-フロ[2',3',4':4,5]ナフト[2,1-c]ピラン-4,9-ジオン19891-51-1C19H24O7
Notoginsenoside R2ノトギンセノシドR280418-25-3C41H70O13
N-acetyl Dapsone-d42070015-08-4C14H10D4N2O3S
Niraparib metabolite M11476777-06-6C19H19N3O2
Norwogonin5,7,8-トリヒドロキシフラボン4443-09-8C15H10O5
NS3861216853-59-7C12H14BrNS
N1,N3,N5-Tris(4-dodecylhexadecyl)benzene-1,3,5-tricarboxamide2922283-38-1C93H177N3O3
NH-3447415-26-1C28H27NO6
Nuvenzepine11-[(1-メチルピペリジン-4-イル)カルボニル]-11H-ピリド[2,3-b][1,5]ベンゾジアゼピン-5(6H)-オン96487-37-5C19H20N4O2
N-β-alanyldopamine hydrochloride58077-93-3C11H17ClN2O3
NSP-8054,5-ジヒドロ-5-メチル-6-[4-[(2-メチル-3-オキソ-1-シクロペンテニル)アミノ]フェニル]ピリダジン-3(2H)-オン125068-54-4C17H19N3O2
Nateglinide-d5ナテグリニド‐D5(フェニル‐D5)1227666-13-8C19H22D5NO3
β-Neo-Endorphinβ-ネオエンドルフィン77739-21-0C54H77N13O12
N-Boc-Phe-Leu-Phe-Leu-Phe148182-34-7C44H59N5O8
NLRP3-IN-131704638-35-6C19H15N3O3S
Nav1.7-IN-21332295-35-8C22H22FN5O2
Nigakinone5-ヒドロキシ-4-メトキシ-6H-インドロ[3,2,1-de][1,5]ナフチリジン-6-オン18110-86-6C15H10N2O3
NUCC-390 dihydrochloride2749281-71-6C23H34ClN5O
NFATc1-IN-11912422-56-0C13H8F2INO2
NSC 6019802070018-27-6C15H12N4
NCT02790245-61-3C17H16N2O2S
Navitoclax-piperazine2143096-93-7C47H56ClF3N6O5S3
NF-κB/MAPK-IN-12413940-56-2C27H27NO7
NPD-13352376326-31-5C28H29N3O3
Nrf2 activator-42383016-68-8C23H24ClF3N2O3
NCI172112スピロムスチン56605-16-4C14H23Cl2N3O2
NHS-SS-Ph2750799-12-1C16H17NO7S2
N6-(4-Hydroxybenzyl)adenosine110505-75-4C17H19N5O5
NPPM 6748-4811-(4-クロロ-3-ニトロベンゾイル)-4-(2-フルオロフェニル)ピペラジン432020-20-7C17H15ClFN3O3
Nitecaponeニテカポン116313-94-1C12H11NO6
NSC 694621104857-29-6C13H10N2O2S
NCGC00029283714240-31-0C18H12FN3O3
NK1 receptor antagonist 2579475-17-5C31H35F7N4O2
NSC 694623907957-34-0C16H16N2OS
NHWD-8702115742-03-3C29H29N7O
NMDI14エチル2-[2-(6,7-ジメチル-3-オキソ-2,4-ジヒドロ-1H-キノキサリン-2-イル)アセトアミド]-4,5-ジメチルチオフェン-3-カルボキシラート307519-88-6C21H25N3O4S
Niga-ichigoside F1ドトリオシドII95262-48-9C36H58O11
NRP1 antagonist 12569598-01-0C22H22N6OS2
NBDHEX787634-60-0C12H15N3O4S
NHE3-IN-292434-13-4C15H12ClN5
NSC639828134742-26-0C18H13BrClN5O3
NLRP3-IN-112769040-91-5C17H17ClN4O2
NemorubicinFCE-23762108852-90-0C32H37NO13
NVS-SM21562333-92-9C23H30N6O
NRC-2694936446-61-6C24H26N4O3
NU63002070015-09-5C20H23N5O3S
NS2B/NS3-IN-32832876-90-9C19H21N3O2
473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530
Copyright 2017 ? ChemicalBook. All rights reserved